Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID:
  • BSEID: 506414
INR
267.15
2.6 (0.98%)
BSENSE

Dec 05

BSE+NSE Vol: 7.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kilitch Drugs
NGL Fine Chem
Fermenta Biotec.
Anuh Pharma
Kopran
Shree Ganesh Rem
Ind-Swift Labs.
Bharat Parenter.
Anlon Healthcare
Remus Pharma.
Influx Health.
Why is Fermenta Biotech Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.52%
  • Poor long term growth as Net Sales has grown by an annual rate of 12.04% and Operating profit at 16.91% over the last 5 years
2
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
3
Below par performance in long term as well as near term
  • Along with generating -35.50% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fermenta Biotec. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Fermenta Biotec.
-35.5%
-0.66
53.50%
Sensex
4.81%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.04%
EBIT Growth (5y)
16.91%
EBIT to Interest (avg)
2.62
Debt to EBITDA (avg)
6.60
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.77
Tax Ratio
14.40%
Dividend Payout Ratio
9.49%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
7.52%
ROE (avg)
8.09%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
7
Industry P/E
34
Price to Book Value
1.99
EV to EBIT
6.88
EV to EBITDA
5.78
EV to Capital Employed
1.86
EV to Sales
1.49
PEG Ratio
0.01
Dividend Yield
0.94%
ROCE (Latest)
27.05%
ROE (Latest)
28.66%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
PBT LESS OI(Q)

At Rs 18.65 cr has Grown at 108.61%

DEBT-EQUITY RATIO(HY)

Lowest at 0.29 times

PAT(Q)

At Rs 18.88 cr has Grown at 65.9%

NET SALES(Q)

At Rs 130.22 cr has Grown at 37.03%

-3What is not working for the Company
OPERATING CF(Y)

Lowest at Rs 40.90 Cr

Loading Valuation Snapshot...
Here's what is working for Fermenta Biotec.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 18.65 cr has Grown at 108.61%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 18.88 cr has Grown at 65.9%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.29 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Net Sales - Quarterly
At Rs 130.22 cr has Grown at 37.03%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Fermenta Biotec.
Operating Cash Flow - Annually
Lowest at Rs 40.90 Cr and Fallen
each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)